{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:51:30Z","timestamp":1790553090047,"version":"4.1.0"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jaut.2021.102707","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T22:14:57Z","timestamp":1628115297000},"page":"102707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus"],"prefix":"10.1016","volume":"123","author":[{"given":"Qianjin","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syarief","family":"Hidayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7594-184X","authenticated-orcid":false,"given":"Retno","family":"Danarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulianto","family":"Listiawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leihong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chak Sing","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong Cheng","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"King Man","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnelfa C.","family":"Paliza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Vicheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Godse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2468-485X","authenticated-orcid":false,"given":"Soyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chew Swee","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Hau","family":"Khang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3056-9412","authenticated-orcid":false,"given":"Rataporn","family":"Ungpakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8223-2769","authenticated-orcid":false,"given":"Hassan","family":"Galadari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmikant","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0323-0376","authenticated-orcid":false,"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3884-962X","authenticated-orcid":false,"given":"Amr H.","family":"Sawalha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaolong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrang-Shi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2021.102707_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jdv.14053","article-title":"S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)","volume":"31","author":"Kuhn","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jaut.2021.102707_bib2","series-title":"AADV\/ASIA Recommendation for the Management of Cutaneous Lupus Erythematosus","author":"Hidayat","year":"2017"},{"issue":"2019","key":"10.1016\/j.jaut.2021.102707_bib3","first-page":"149","article-title":"Chinese Society of Dermatology, Guideline for diagnosis and treatment of cutaneous lupus erythematosus","volume":"52","year":"2019","journal-title":"Chin. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/M16-1565","article-title":"A reporting tool for practice guidelines in health care: the RIGHT statement","volume":"166","author":"Chen","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2021.102707_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2018.07.007","article-title":"A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus","volume":"93","author":"Li","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102707_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jaad.2015.12.029","article-title":"Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE)","volume":"74","author":"Tiao","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/0961203312474703","article-title":"Annular subacute cutaneous lupus erythematosus lesions and polymyositis onset in a patient with primary Sjogren's syndrome: how should this unusual association be classified?","volume":"22","author":"Bernacchi","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2021.102707_bib8","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.1111\/jdv.14239","article-title":"A case of chilblain lupus erythematosus with lupus erythematosus\/lichen planus overlap syndrome","volume":"31","author":"Komori","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jaut.2021.102707_bib9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/bjd.17245","article-title":"Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy","volume":"181","author":"Marano","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.autrev.2018.03.011","article-title":"Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: analysis of a cohort of 214 patients","volume":"17","author":"Paule","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102707_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2021.02.043","article-title":"A deep learning-based smartphone platform for cutaneous lupus erythematosus classification assistance: simplifying the diagnosis of complicated diseases","author":"Wu","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.21037\/atm.2020.04.39","article-title":"A deep learning, image based approach for automated diagnosis for inflammatory skin diseases","volume":"8","author":"Wu","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jaut.2021.102707_bib13","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1136\/annrheumdis-2015-208410","article-title":"IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus","volume":"75","author":"Zhao","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102707_bib14","doi-asserted-by":"crossref","first-page":"100092","DOI":"10.1016\/j.jtauto.2021.100092","article-title":"Difference of IFI44L methylation and serum IFN-a1 level among patients with discoid and systemic lupus erythematosus and healthy individuals","volume":"4","author":"Zhang","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.jaut.2021.102707_bib15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.0022-202X.2005.23889.x","article-title":"The CLASI (cutaneous lupus erythematosus disease area and severity index): an outcome instrument for cutaneous lupus erythematosus","volume":"125","author":"Albrecht","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.2010.09799.x","article-title":"Revised cutaneous lupus erythematosus disease area and severity index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus","volume":"163","author":"Kuhn","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1468-3083.2010.03844.x","article-title":"Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI","volume":"25","author":"Bein","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jaut.2021.102707_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1067\/mjd.2001.114589","article-title":"Phototesting in lupus erythematosus: a 15-year experience","volume":"45","author":"Kuhn","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2009.12.053","article-title":"Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: a randomized, vehicle-controlled, double-blind study","volume":"64","author":"Kuhn","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib20","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1177\/0961203315596077","article-title":"A multicenter photoprovocation study to identify potential biomarkers by global peptide profiling in cutaneous lupus erythematosus","volume":"24","author":"Calderon","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2021.102707_bib21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/exd.12035","article-title":"Suppression of UV-induced damage by a liposomal sunscreen: a prospective, open-label study in patients with cutaneous lupus erythematosus and healthy controls","volume":"21","author":"Patsinakidis","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/art.21658","article-title":"Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation","volume":"54","author":"Kuhn","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102707_bib23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2133.2010.09948.x","article-title":"Vitamin D deficiency in patients with cutaneous lupus erythematosus is prevalent throughout the year","volume":"163","author":"Heine","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib24","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0961203309360807","article-title":"Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region","volume":"19","author":"Cutillas-Marco","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2021.102707_bib25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/0961203314522338","article-title":"Vitamin D and cutaneous lupus erythematosus: effect of vitamin D replacement on disease severity","volume":"23","author":"Cutillas-Marco","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2021.102707_bib26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/bjd.13006","article-title":"Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database","volume":"171","author":"Kuhn","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jaad.2014.12.025","article-title":"Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature","volume":"72","author":"Chasset","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib28","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archdermatol.2009.199","article-title":"Association of cigarette smoking but not alcohol consumption with cutaneous lupus erythematosus","volume":"145","author":"Boeckler","year":"2009","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib29","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/0961203320930094","article-title":"Cutaneous lupus erythematosus: factors related to cutaneous activity and damage in a cohort of 260 patients from A Coru\u00f1a, Spain","volume":"29","author":"Ar\u00e9valo-Berm\u00fadez","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2021.102707_bib30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/BOR.0000000000000522","article-title":"Drug-induced lupus erythematosus: an update on drugs and mechanisms","volume":"30","author":"He","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102707_bib31","first-page":"465","article-title":"A systematic review of drug-induced subacute cutaneous lupus erythematosus","volume":"164","author":"Lowe","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1684\/ejd.2016.2912","article-title":"Drug-induced cutaneous lupus erythematosus: 88 new cases","volume":"27","author":"Laurinaviciene","year":"2017","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib33","first-page":"54","article-title":"Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT)","volume":"11","author":"Yoshimasu","year":"2001","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib34","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0961203309106176","article-title":"Drug-induced lupus: an update on its dermatologic aspects","volume":"18","author":"Marzano","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2021.102707_bib35","doi-asserted-by":"crossref","first-page":"102705","DOI":"10.1016\/j.autrev.2020.102705","article-title":"Characterization of drug-induced cutaneous lupus: analysis of 1994 cases using the WHO pharmacovigilance database","volume":"20","author":"Kawka","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102707_bib36","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/jocd.13189","article-title":"A secondary discoid lupus erythematosus induced by scald of edible oil: an illustration of Koebner phenomenon","volume":"19","author":"Ji","year":"2020","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0961203318815578","article-title":"Koebner phenomenon of discoid lupus erythematosus on old tattoos","volume":"28","author":"Wang","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2021.102707_bib38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/art.21334","article-title":"Discoid lupus erythematosus after tattoo: Koebner phenomenon","volume":"53","author":"Jolly","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102707_bib39","first-page":"475","article-title":"Nickel-induced Koebner phenomenon in chronic cutaneous lupus erythematosus","volume":"9","author":"Lukacs","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaut.2021.102707_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5070\/D39PV1N9F6","article-title":"Koebner phenomenon to heat in cutaneous (discoid) lupus erythematosus (lupus ab-igne)","volume":"18","author":"Berger","year":"2012","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.jaut.2021.102707_bib41","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102707_bib42","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","article-title":"A trial of contraceptive methods in women with systemic lupus erythematosus","volume":"353","author":"S\u00e1nchez-Guerrero","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102707_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104303","article-title":"Safety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"9","author":"Rojas-Villarraga","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2021.102707_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1748-717X-7-22","article-title":"Acute and late toxicities of radiotherapy for patients with discoid lupus erythematosus: a retrospective case-control study","volume":"7","author":"Patel","year":"2012","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.jaut.2021.102707_bib45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.20912","article-title":"Role of radiation therapy in patients with a diagnosis of both systemic lupus erythematosus and cancer","volume":"53","author":"Benk","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102707_bib46","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/ddg.13888","article-title":"Cutaneous lupus erythematosus induced by radiotherapy for breast carcinoma","volume":"17","author":"Durmaz","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaut.2021.102707_bib47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000354721","article-title":"Subacute cutaneous lupus erythematosus triggered by radiotherapy","volume":"5","author":"Kolm","year":"2013","journal-title":"Case Rep. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib48","first-page":"CD002954","article-title":"Drugs for discoid lupus erythematosus","volume":"5","author":"Jessop","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jaut.2021.102707_bib49","first-page":"281","article-title":"Discoid lupus erythematosus. Diagnostic features and evaluation of topical corticosteroid therapy","volume":"25","author":"Roenigk","year":"1980","journal-title":"Cutis"},{"key":"10.1016\/j.jaut.2021.102707_bib50","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2230.2008.03138.x","article-title":"Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study","volume":"34","author":"Barikbin","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib51","first-page":"933","article-title":"A comparative study in efficacy and safety of 0.1% tacrolimus and 0.05% clobetasol propionate ointment in discoid lupus erythematosus by modified cutaneous lupus erythematosus disease area and severity index","volume":"95","author":"Pothinamthong","year":"2012","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.jaut.2021.102707_bib52","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/BOR.0000000000000704","article-title":"Treatment of cutaneous lupus erythematosus: current approaches and future strategies","volume":"32","author":"Shi","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102707_bib53","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.berh.2013.07.008","article-title":"Cutaneous lupus erythematosus: diagnosis and treatment","volume":"27","author":"Okon","year":"2013","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102707_bib54","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11926-011-0180-z","article-title":"Treatment of cutaneous lupus","volume":"13","author":"Chang","year":"2011","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jaut.2021.102707_bib55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1053\/sder.2001.23091","article-title":"Cutaneous lupus erythematosus","volume":"20","author":"McCauliffe","year":"2001","journal-title":"Semin. Cutan. Med. Surg."},{"key":"10.1016\/j.jaut.2021.102707_bib56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2010.03.037","article-title":"Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial","volume":"65","author":"Kuhn","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib57","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/jcph.537","article-title":"Tacrolimus 0.03% ointment in labial discoid lupus erythematosus: a randomized, controlled clinical trial","volume":"55","author":"Wang","year":"2015","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jaut.2021.102707_bib58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2230.2009.03351.x","article-title":"Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study","volume":"35","author":"Madan","year":"2010","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib59","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2004.01.044","article-title":"Pimecrolimus 1% cream for cutaneous lupus erythematosus","volume":"51","author":"Kreuter","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib60","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/rheumatology\/kei093","article-title":"Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus","volume":"44","author":"Tlacuilo-Parra","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2021.102707_bib61","first-page":"351","article-title":"Cutaneous lupus treated with topical tretinoin: a case report","volume":"47","author":"Seiger","year":"1991","journal-title":"Cutis"},{"key":"10.1016\/j.jaut.2021.102707_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D30R49C68V","article-title":"Two cases of refractory discoid lupus erythematosus successfully treated with topical to coretinate","volume":"17","author":"Terao","year":"2011","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.jaut.2021.102707_bib63","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0190-9622(99)70278-1","article-title":"Treatment of localized discoid lupus erythematosus with tazarotene","volume":"41","author":"Edwards","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/09546634.2018.1468063","article-title":"Pulsed-dye laser as an adjuvant treatment for discoid lupus erythematosus: a randomized, controlled trial","volume":"30","author":"Rerknimitr","year":"2019","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.jaut.2021.102707_bib65","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ad.2018.03.020","article-title":"Usefulness of pulsed dye laser in cutaneous lupus erythematosus","volume":"110","author":"Garc\u00eda-Montero","year":"2019","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaut.2021.102707_bib66","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10103-016-2131-4","article-title":"Treatment of lupus erythematosus of the eyelids with pulsed dye laser","volume":"33","author":"Br\u00e1s","year":"2018","journal-title":"Laser Med. Sci."},{"key":"10.1016\/j.jaut.2021.102707_bib67","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1524-4725.2011.02041.x","article-title":"Histopathology and immunohistochemistry of cutaneous lupus erythematosus after pulsed dye laser treatment","volume":"37","author":"Diez","year":"2011","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.jaut.2021.102707_bib68","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1468-3083.2011.04281.x","article-title":"Pulsed dye laser as an excellent choice of treatment for lupus tumidus: a prospective study","volume":"26","author":"Truchuelo","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jaut.2021.102707_bib69","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/14764172.2013.787802","article-title":"Laser therapy for refractory discoid lupus erythematosus when everything else has failed","volume":"15","author":"Ekb\u00e4ck","year":"2013","journal-title":"J. Cosmet. Laser Ther. : Off. Publ. Eur. Soc. Laser Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/pde.12248","article-title":"Pediatric cutaneous lupus erythematosus treated with pulsed dye laser","volume":"31","author":"Y\u00e9lamos","year":"2014","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib71","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaad.2008.11.904","article-title":"Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus","volume":"60","author":"Erceg","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib72","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/lsm.10169","article-title":"Treatment of lupus erythematosus with pulsed dye laser","volume":"32","author":"Baniandr\u00e9s","year":"2003","journal-title":"Laser Surg. Med."},{"key":"10.1016\/j.jaut.2021.102707_bib73","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1046\/j.1365-2133.1999.03203.x","article-title":"Cutaneous lupus erythematosus-treatment with pulsed dye laser","volume":"141","author":"Raulin","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib74","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archderm.1996.03890270132027","article-title":"Pulsed dye laser treatment of telangiectatic chronic erythema of cutaneous lupus erythematosus","volume":"132","author":"N\u00fa\u00f1ez","year":"1996","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib75","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1365-2133.1995.tb06945.x","article-title":"Pulsed dye laser treatment in lupus erythematosus telangiectoides","volume":"133","author":"N\u00fa\u00f1ez","year":"1995","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib76","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.40018","article-title":"Effects of hydroxychloroquine in patients with cutaneous lupus erythematosus: a multicenter, double-blind, randomized, parallel-group trial","volume":"69","author":"Yokogawa","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102707_bib77","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2133.1992.tb14851.x","article-title":"Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine","volume":"127","author":"Ruzicka","year":"1992","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib78","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1002\/art.21358","article-title":"Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus","volume":"52","author":"Bezerra","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102707_bib79","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.autrev.2012.10.005","article-title":"Therapeutic strategies evaluated by the European society of cutaneous lupus erythematosus (EUSCLE) Core set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus","volume":"12","author":"Sigges","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102707_bib80","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/1346-8138.14802","article-title":"Varied responses to and efficacies of hydroxychloroquine treatment according to cutaneous lupus erythematosus subtypes in Japanese patients","volume":"46","author":"Ototake","year":"2019","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib81","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaut.2021.102707_bib82","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)","volume":"123","author":"Marmor","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaut.2021.102707_bib83","article-title":"Safety management in treatment with antimalarials in rheumatology. Interdisciplinary recommendations on the basis of a systematic literature review","author":"Fiehn","year":"2020","journal-title":"Zeitschrift Rheumatol."},{"key":"10.1016\/j.jaut.2021.102707_bib84","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archdermatol.2011.191","article-title":"Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis","volume":"147","author":"Chang","year":"2011","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib85","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1610-0387.2008.06640.x","article-title":"Peas, beans, and the Pythagorean theorem - the relevance of glucose-6-phosphate dehydrogenase deficiency in dermatology","volume":"6","author":"Brandt","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaut.2021.102707_bib86","first-page":"27","article-title":"Treatment of cutaneous lupus erythematosus: review and assessment of treatment benefits based on oxford Centre for evidence-based medicine criteria","volume":"6","author":"Winkelmann","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaut.2021.102707_bib87","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1529-8019.2012.01508.x","article-title":"Cutaneous lupus erythematosus","volume":"25","author":"Hansen","year":"2012","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jaut.2021.102707_bib88","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00198-015-3200-4","article-title":"Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996-2012","volume":"26","author":"Albaum","year":"2015","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.jaut.2021.102707_bib89","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jdv.14053","article-title":"S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)","volume":"31","author":"Kuhn","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jaut.2021.102707_bib90","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1365-2133.2011.10693.x","article-title":"Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome","volume":"166","author":"Cortes-Hernandez","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib91","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-4362.2000.00953.x","article-title":"Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus","volume":"39","author":"Kyriakis","year":"2000","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib92","first-page":"1429","article-title":"Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy","volume":"27","author":"Ordi-Ros","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102707_bib93","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/rheumatology\/36.3.353","article-title":"Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients","volume":"36","author":"Stevens","year":"1997","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102707_bib94","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.amjmed.2004.04.030","article-title":"Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens","volume":"118","author":"Cuadrado","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2021.102707_bib95","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semarthrit.2019.07.010","article-title":"Management of cutaneous manifestations of lupus erythematosus: a systematic review","volume":"50","author":"Fairley","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102707_bib96","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1186\/ar4111","article-title":"Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus","volume":"14","author":"Cortes-Hernandez","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2021.102707_bib97","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1111\/ijd.13226","article-title":"Lenalidomide treatment of cutaneous lupus erythematosus: the Mayo Clinic experience","volume":"55","author":"Kindle","year":"2016","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib98","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ard.2003.019323","article-title":"Lupus erythematosus with leflunomide: induction or reactivation?","volume":"64","author":"Gensburger","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102707_bib99","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0190-9622(96)90039-0","article-title":"Guidelines of care for cutaneous lupus erythematosus. American Academy of Dermatology","volume":"34","author":"Drake","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1529-8019.2012.01461.x","article-title":"Treatment of refractory subacute cutaneous lupus erythematosus with oral isotretinoin: a valid therapeutic option","volume":"25","author":"D'Erme","year":"2012","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jaut.2021.102707_bib101","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0190-9622(91)70008-P","article-title":"Isotretinoin for refractory lupus erythematosus","volume":"24","author":"Shornick","year":"1991","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib102","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0190-9622(86)70111-4","article-title":"Keratotic lupus erythematosus: treatment with isotretinoin","volume":"14","author":"Rubenstein","year":"1986","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib103","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1346-8138.2005.tb00785.x","article-title":"Hypertrophic lupus erythematosus treated successfully with acitretin as monotherapy","volume":"32","author":"Al-Mutairi","year":"2005","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib104","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/archderm.1988.01670060043013","article-title":"Efficiency of acitretin in the treatment of cutaneous lupus erythematosus","volume":"124","author":"Ruzicka","year":"1988","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.semarthrit.2017.11.003","article-title":"Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases","volume":"48","author":"de Risi-Pugliese","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102707_bib106","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/key434","article-title":"Dapsone: an old drug effective for subacute cutaneous lupus erythematosus","volume":"58","author":"Zampeli","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2021.102707_bib107","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/dth.12358","article-title":"Review of treatment for discoid lupus erythematosus","volume":"29","author":"Garza-Mayers","year":"2016","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jaut.2021.102707_bib108","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/00128071-200304070-00002","article-title":"Cutaneous lupus erythematosus: diagnosis and management","volume":"4","author":"Fabbri","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib109","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000441054","article-title":"Dapsone as second-line treatment for cutaneous lupus erythematosus? A retrospective analysis of 34 patients and a review of the literature","volume":"232","author":"Klebes","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.jaut.2021.102707_bib110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archderm.142.3.399","article-title":"Lupus erythematosus profundus successfully treated with dapsone: review of the literature","volume":"142","author":"Ujiie","year":"2006","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib111","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","article-title":"HLA-B*13:01 and the dapsone hypersensitivity syndrome","volume":"369","author":"Zhang","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102707_bib112","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1756-185X.2011.01665.x","article-title":"Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus","volume":"15","author":"Islam","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jaut.2021.102707_bib113","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2133.2005.06552.x","article-title":"Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients","volume":"153","author":"Wenzel","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib114","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s002960050058","article-title":"Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms","volume":"18","author":"Boehm","year":"1998","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2021.102707_bib115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2133.2005.06552.x","article-title":"Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients","volume":"153","author":"Wenzel","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib116","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40257-013-0017-9","article-title":"The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA","volume":"14","author":"Al-Dabagh","year":"2013","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib117","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102707_bib118","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3899\/jrheum.130738","article-title":"Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis","volume":"41","author":"Shea","year":"2014","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102707_bib119","article-title":"Safety and tolerability of subcutaneous methotrexate in routine clinical practice","author":"Li","year":"2020","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2021.102707_bib120","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1001\/archderm.138.12.1616","article-title":"Mycophenolate mofetil for the treatment of cutaneous lupus erythematosus with smoldering systemic involvement","volume":"138","author":"Hanjani","year":"2002","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib121","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaad.2010.08.011","article-title":"Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus","volume":"65","author":"Gammon","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib122","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1365-2133.2007.07826.x","article-title":"Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy","volume":"156","author":"Kreuter","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib123","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.jaad.2020.05.058","article-title":"Belimumab for refractory manifestations of cutaneous lupus: a multicenter, retrospective observational study of 16 patients","volume":"83","author":"Salle","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib124","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/annrheumdis-2017-211631","article-title":"A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea","volume":"77","author":"Zhang","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102707_bib125","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102707_bib126","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2021.102707_bib127","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1177\/0961203310378669","article-title":"Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia","volume":"19","author":"Al Arfaj","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2021.102707_bib128","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaip.2020.07.047","article-title":"Oral corticosteroids and risk of preterm birth in the California medicaid program","volume":"9","author":"Palmsten","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaut.2021.102707_bib129","first-page":"CD007346","article-title":"Safety of topical corticosteroids in pregnancy","author":"Chi","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jaut.2021.102707_bib130","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2133.2008.08974.x","article-title":"Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis","volume":"160","author":"Undre","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib131","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s40620-018-0477-3","article-title":"Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era","volume":"31","author":"Colla","year":"2018","journal-title":"J. Nephrol."},{"key":"10.1016\/j.jaut.2021.102707_bib132","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/bdr2.1745","article-title":"Teratogen update: topical use and third-generation retinoids","volume":"112","author":"Williams","year":"2020","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.jaut.2021.102707_bib133","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/bdr2.1799","article-title":"Risk management of teratogenic medicines: a systematic review","volume":"112","author":"Shroukh","year":"2020","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.jaut.2021.102707_bib134","article-title":"Mycophenolic acid area under the concentration-time curve is associated with therapeutic response in childhood-onset lupus nephritis","author":"Godron-Dubrasquet","year":"2020","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.jaut.2021.102707_bib135","first-page":"845","article-title":"Management of central nervous system tuberculosis in children: light and shade","volume":"14","author":"Buonsenso","year":"2010","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jaut.2021.102707_bib136","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jaad.2015.01.002","article-title":"Review of thalidomide use in the pediatric population","volume":"72","author":"Yang","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib137","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2133.1996.45767.x","article-title":"Chilblain lupus erythematosus of Hutchinson responding to surgical treatment: a report of two patients with anti-Ro\/SS-A antibodies","volume":"134","author":"Aoki","year":"1996","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102707_bib138","first-page":"163","article-title":"Medical and surgical treatment for discoid lupus erythematosus","volume":"18","author":"di Meo","year":"2010","journal-title":"Acta Dermatovenerol. Croat."},{"key":"10.1016\/j.jaut.2021.102707_bib139","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.revmed.2014.07.012","article-title":"[The pre-pregnancy counseling]","volume":"36","author":"Le Guern","year":"2015","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.jaut.2021.102707_bib140","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.annder.2015.07.015","article-title":"Pregnancy and contraception in systemic and cutaneous lupus erythematosus","volume":"143","author":"Guettrot-Imbert","year":"2016","journal-title":"Ann. Dermatol. Venereol."},{"key":"10.1016\/j.jaut.2021.102707_bib141","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.revmed.2014.07.013","article-title":"[Neonatal lupus syndrome: literature review]","volume":"36","author":"Morel","year":"2015","journal-title":"Rev. Med. Interne"},{"issue":"2019","key":"10.1016\/j.jaut.2021.102707_bib142","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"European League against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102707_bib143","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/ard.2007.070847","article-title":"BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000","volume":"67","author":"Yee","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102707_bib144","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J. Rheumatol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121001153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121001153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:31:30Z","timestamp":1760257890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841121001153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":144,"alternative-id":["S0896841121001153"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102707","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102707"}}